Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) FCF Margin (2019 - 2023)

Historic FCF Margin for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to 257.6%.

  • ADC Therapeutics' FCF Margin fell 2576000.0% to 257.6% in Q3 2023 from the same period last year, while for Dec 2023 it was 231.02%, marking a year-over-year decrease of 2308200.0%. This contributed to the annual value of 66218.53% for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q3 2023, ADC Therapeutics' FCF Margin is 257.6%, which was down 2576000.0% from 187.73% recorded in Q2 2023.
  • ADC Therapeutics' 5-year FCF Margin high stood at 0.0% for Q3 2022, and its period low was 21690.54% during Q1 2020.
  • Moreover, its 5-year median value for FCF Margin was 86.39% (2023), whereas its average is 3076.67%.
  • Per our database at Business Quant, ADC Therapeutics' FCF Margin soared by 3621200bps in 2022 and then tumbled by -2576000bps in 2023.
  • Quarter analysis of 5 years shows ADC Therapeutics' FCF Margin stood at 15159.91% in 2019, then plummeted by -43bps to 21690.54% in 2020, then surged by 98bps to 362.32% in 2021, then surged by 100bps to 0.2% in 2022, then crashed by -129976bps to 257.6% in 2023.
  • Its FCF Margin was 257.6% in Q3 2023, compared to 187.73% in Q2 2023 and 86.39% in Q1 2023.